HRMY
Harmony Biosciences Holdings
40.50$
-2.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -1,258.3% | -1.9% | 32.3% | 33.0% | 37.7% | 30.8% | 40.1% | |
| – | 63.4% | 6.4% | 6.9% | 5.7% | 4.2% | 3.4% | 2.9% | |
| – | 165.3% | 2.9% | 5.3% | 6.1% | 5.4% | 6.0% | 5.2% | |
| – | 1,075.0% | 20.6% | 13.8% | -13.3% | – | – | – | |
| – | 56.6% | -7.3% | 0.7% | -1.6% | 6.0% | -1.0% | 10.6% | |
| – | 2.5% | 1.3% | 0.1% | 0.0% | 0.1% | 0.2% | 0.0% | |
| – | -2,120.9% | -1.3% | -32.8% | -32.4% | -8.0% | -9.4% | -4.6% | |
| – | 2,398.1% | 125.4% | – | – | 0.9% | – | – | |
| – | -18.9% | -0.1% | 12.8% | 2.0% | -17.2% | 0.0% | 0.0% | |
| – | 1,668.1% | 61.0% | -0.2% | -0.5% | -0.2% | -2.1% | -1.9% | |
| – | 2,398.1% | 130.9% | 2.4% | 1.6% | -18.1% | -1.5% | -1.0% | |
| – | -981.1% | 127.8% | 1.9% | 2.2% | 11.6% | 19.8% | 34.5% | |
| – | -1,260.8% | -3.1% | 32.2% | 33.0% | 37.6% | 30.6% | 40.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.